Ganfeng Lithium Co., Limited (1772.HK)
HKD 18.8
(-2.19%)
HKD 18.8
(-2.19%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 8.26 Billion CNY | -18.27% |
| 2022 | 10.11 Billion CNY | 207.95% |
| 2021 | 3.28 Billion CNY | 48.24% |
| 2020 | 2.21 Billion CNY | -5.1% |
| 2019 | 2.33 Billion CNY | 22.53% |
| 2018 | 1.9 Billion CNY | 108.2% |
| 2017 | 914.83 Million CNY | 71.2% |
| 2016 | 534.35 Million CNY | 70.64% |
| 2015 | 313.14 Million CNY | -4.85% |
| 2014 | 329.09 Million CNY | 49.99% |
| 2013 | 219.4 Million CNY | 18.28% |
| 2012 | 185.5 Million CNY | 53.41% |
| 2011 | 120.92 Million CNY | 46.41% |
| 2010 | 82.59 Million CNY | 77.17% |
| 2009 | 46.61 Million CNY | -40.83% |
| 2008 | 78.78 Million CNY | 74.63% |
| 2007 | 45.11 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 6.96 Billion CNY | -15.7% |
| 2024 Q2 | 8.12 Billion CNY | 16.57% |
| 2023 Q2 | 11.35 Billion CNY | 13.54% |
| 2023 Q1 | 10 Billion CNY | -1.06% |
| 2023 Q3 | 10.92 Billion CNY | -3.83% |
| 2023 FY | 8.26 Billion CNY | -18.27% |
| 2023 Q4 | 8.26 Billion CNY | -24.35% |
| 2022 FY | 10.11 Billion CNY | 207.95% |
| 2022 Q1 | 4.05 Billion CNY | 23.5% |
| 2022 Q2 | 7 Billion CNY | 72.84% |
| 2022 Q3 | 8.52 Billion CNY | 21.62% |
| 2022 Q4 | 10.11 Billion CNY | 18.63% |
| 2021 Q3 | 2.62 Billion CNY | 5.32% |
| 2021 Q1 | 2.46 Billion CNY | 11.39% |
| 2021 FY | 3.28 Billion CNY | 48.24% |
| 2021 Q2 | 2.49 Billion CNY | 1.14% |
| 2021 Q4 | 3.28 Billion CNY | 24.93% |
| 2020 Q4 | 2.21 Billion CNY | 8.61% |
| 2020 Q2 | 2.3 Billion CNY | 0.85% |
| 2020 Q1 | 2.28 Billion CNY | -2.26% |
| 2020 FY | 2.21 Billion CNY | -5.1% |
| 2020 Q3 | 2.03 Billion CNY | -11.35% |
| 2019 Q1 | 1.83 Billion CNY | -3.89% |
| 2019 FY | 2.33 Billion CNY | 22.53% |
| 2019 Q4 | 2.33 Billion CNY | 19.65% |
| 2019 Q3 | 1.95 Billion CNY | -1.91% |
| 2019 Q2 | 1.98 Billion CNY | 8.62% |
| 2018 FY | 1.9 Billion CNY | 108.2% |
| 2018 Q1 | 1.14 Billion CNY | 25.53% |
| 2018 Q2 | 1.29 Billion CNY | 12.76% |
| 2018 Q3 | 1.4 Billion CNY | 8.34% |
| 2018 Q4 | 1.9 Billion CNY | 35.77% |
| 2017 Q2 | 842.4 Million CNY | 26.89% |
| 2017 FY | 914.83 Million CNY | 71.2% |
| 2017 Q4 | 914.83 Million CNY | 7.05% |
| 2017 Q3 | 854.55 Million CNY | 1.44% |
| 2017 Q1 | 663.89 Million CNY | 24.24% |
| 2016 FY | 534.35 Million CNY | 70.64% |
| 2016 Q1 | 510.6 Million CNY | 63.06% |
| 2016 Q4 | 534.35 Million CNY | -10.47% |
| 2016 Q2 | 519.7 Million CNY | 1.78% |
| 2016 Q3 | 596.81 Million CNY | 14.84% |
| 2015 Q2 | 366.67 Million CNY | -1.87% |
| 2015 FY | 313.14 Million CNY | -4.85% |
| 2015 Q4 | 313.14 Million CNY | -15.64% |
| 2015 Q3 | 371.2 Million CNY | 1.24% |
| 2015 Q1 | 373.64 Million CNY | 13.54% |
| 2014 Q2 | 292.39 Million CNY | 19.22% |
| 2014 FY | 329.09 Million CNY | 49.99% |
| 2014 Q4 | 329.09 Million CNY | 2.47% |
| 2014 Q3 | 321.15 Million CNY | 9.84% |
| 2014 Q1 | 245.26 Million CNY | 11.78% |
| 2013 Q4 | 219.4 Million CNY | 3.62% |
| 2013 FY | 219.4 Million CNY | 18.28% |
| 2013 Q1 | 210.6 Million CNY | 13.53% |
| 2013 Q2 | 224.96 Million CNY | 6.82% |
| 2013 Q3 | 211.75 Million CNY | -5.87% |
| 2012 Q1 | 141.64 Million CNY | 17.14% |
| 2012 FY | 185.5 Million CNY | 53.41% |
| 2012 Q2 | 130.53 Million CNY | -7.84% |
| 2012 Q3 | 145.85 Million CNY | 11.74% |
| 2012 Q4 | 185.5 Million CNY | 27.18% |
| 2011 FY | 120.92 Million CNY | 46.41% |
| 2011 Q1 | 90.6 Million CNY | 9.7% |
| 2011 Q3 | 122.45 Million CNY | 6.72% |
| 2011 Q2 | 114.75 Million CNY | 26.65% |
| 2011 Q4 | 120.92 Million CNY | -1.25% |
| 2010 FY | 82.59 Million CNY | 77.17% |
| 2010 Q2 | 79.91 Million CNY | 0.0% |
| 2010 Q4 | 82.59 Million CNY | -1.66% |
| 2010 Q3 | 83.98 Million CNY | 5.1% |
| 2009 Q4 | 46.61 Million CNY | 0.0% |
| 2009 FY | 46.61 Million CNY | -40.83% |
| 2008 FY | 78.78 Million CNY | 74.63% |
| 2007 FY | 45.11 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 37.57 Million HKD | -21892.056% |
| Lee & Man Chemical Company Limited | 787.74 Million HKD | -949.059% |